COAGULATION CHANGES AND THE INFLUENCE OF THE EARLY PERFUSATE IN THE COURSE OF ORTHOTOPIC LIVER-TRANSPLANTATION (OLT) WHEN APROTININ IS USED INTRA-OPERATIVELY

被引:28
作者
HIMMELREICH, G
KIERZEK, B
NEUHAUS, P
SLAMER, KJ
JOCHUM, M
RIESS, H
机构
[1] UNIV MUNICH,CHIRURG KLIN INNENSTADT,DEPT CLIN CHEM & CLIN BIOCHEM,W-8000 MUNICH 2,GERMANY
[2] TECH UNIV BERLIN,KLINIKUM RUDOLF VIRCHOW,DEPT INTERNAL MED,W-1000 BERLIN 19,GERMANY
[3] TECH UNIV BERLIN,KLINIKUM RUDOLF VIRCHOW,DEPT SURG,W-1000 BERLIN 19,GERMANY
[4] TECH UNIV BERLIN,KLINIKUM RUDOLF VIRCHOW,INST ANESTHESIOL,W-1000 BERLIN 19,GERMANY
关键词
ORTHOTOPIC LIVER TRANSPLANTATION; APROTININ; HYPERFIBRINOLYSIS; TISSUE-PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; THROMBIN-ANTITHROMBIN-III COMPLEXES; DISSEMINATED INTRAVASCULAR COAGULATION; PERFUSATE;
D O I
10.1097/00001721-199102000-00008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The changes in relevant haemostatic parameters during the course of ten orthotopic liver transplantation were studied when aprotinin was given intra-operatively. Increases of tissue-type (P = 0.008) and urokinase-type (P = 0.009) plasminogen activators during the anhepatic phase could be correlated with hyperfibrinolysis. Thrombin - antithrombin III complexes (TAT) increased after revascularization of the liver graft (P = 0.003). Parallel studies in the perfusate showed that TAT concentrations were 350% and protease inhibitor activities (antithrombin III, protein C) only 52% of the systemic circulation before reperfusion, suggesting that thrombin activation together with protease inhibitor consumption occurs during graft liver reperfusion. The relatively smaller increases in profibrinolytic parameters and a lower blood loss when compared with other groups may be explained by aprotinin administration in our patients.
引用
收藏
页码:51 / 58
页数:8
相关论文
共 20 条
  • [1] BACHMANN F, 1987, THROMB DIATH HAEMO, P227
  • [2] BIDSTRUP BP, 1986, J THORAC CARDIOVASC, V91, P436
  • [3] CLASEN C, 1987, 1ST VIENN SHOCK FO A, P175
  • [4] REDUCTION OF HOMOLOGOUS BLOOD REQUIREMENT IN CARDIAC-SURGERY BY INTRAOPERATIVE APROTININ APPLICATION - CLINICAL-EXPERIENCE IN 152 CARDIAC SURGICAL PATIENTS
    DIETRICH, W
    BARANKAY, A
    DILTHEY, G
    HENZE, R
    NIEKAU, E
    SEBENING, F
    RICHTER, JA
    [J]. THORACIC AND CARDIOVASCULAR SURGEON, 1989, 37 (02) : 92 - 98
  • [5] DZIK WH, 1988, BLOOD, V71, P1090
  • [6] FRITZ H, 1983, ARZNEIMITTELFORSCH, V33-1, P479
  • [7] HABERLAND GL, 1967, MED WELT, V18, P1367
  • [8] HARPER PL, 1989, TRANSPLANTATION, V48, P603
  • [9] ASSAY CHARACTERISTICS AND FIBRIN AFFINITY OF PLASMINOGEN ACTIVATORS OF THE INTRINSIC FIBRINOLYTIC SYSTEM
    KOK, P
    NILSSON, T
    [J]. THROMBOSIS RESEARCH, 1986, 41 (02) : 197 - 209
  • [10] MADDREY WC, 1988, HEPATOLOGY, V8, P259